Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus

Atherosclerosis

Volumn 251, Issue , 2016, Pages 334-338

  Kiec Wilk, Beata ^a,b   Matejko, Bartlomiej ^a   Razny, Urszula ^a   Stankiewicz, Magdalena ^b   Skupien, Jan ^a,b   Klupa, Tomasz ^a,b   Malecki, Maciej T ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Diabetes type 1; Endothelial dysfunction; Inflammation; Mild hypoglycemia; Short communication

Indexed keywords

ALBUMIN; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEVOTHYROXINE; VASCULAR CELL ADHESION MOLECULE 1; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; ICAM1 PROTEIN, HUMAN; INSULIN; SELE PROTEIN, HUMAN;

ADULT; ALBUMIN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY WEIGHT; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ANALYSIS; BLOOD; COHORT ANALYSIS; COMPLICATION; DIABETIC COMPLICATION; INFLAMMATION; INFUSION PUMP; MIDDLE AGED;

ADULT; BIOMARKERS; BLOOD GLUCOSE; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; E-SELECTIN; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFLAMMATION; INFUSION PUMPS; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84969814742     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.05.002     Document Type: Article

References (11)

1. [1] Lind, M., Svensson, A.M., Kosiborod, M., et al. Glycemic control and excess mortality in type 1 diabetes. N. Engl. J. Med. 371:21 (2014), 1972–1982.
2. [2] Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein, H.C., Miller, M.E., Byington, R.P., Goff, D.C. Jr., Bigger, J.T., et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358:24 (2008), 2545–2559.
3. [3] Heier, M., Margeirsdottir, H.D., Brunborg, C., Hanssen, K.F., Dahl-Jørgensen, K., Seljeflot, I., Inflammation in childhood type 1 diabetes; influence of glycemic control. Atherosclerosis 238:1 (2015), 33–37.
4. [4] Gogitidze Joy, N., Hedrington, M.S., Briscoe, V.J., Tate, D.B., Ertl, A.C., Davis, S.N., Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 33:7 (2010), 1529–1535.
5. [5] Lung, T.W., Petrie, D., Herman, W.H., et al. Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden. Diabetes Care 37:11 (2014), 2974–2981.
6. [6] Limberg, J.K., Farni, K.E., Taylor, J.L., et al. Autonomic control during acute hypoglycemia in type 1 diabetes mellitus. Clin. Auton. Res. 24:6 (2014), 275–283.
7. [7] Yasunari, E., Mita, T., Osonoi, Y., Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery. Endocrinology 155:6 (2014), 2244–2253.
8. [8] Hoffman, R.P., Dye, A.S., Huang, H., Bauer, J.A., Effects of glucose control and variability on endothelial function and repair in adolescents with type 1 diabetes. ISRN Endocrinol., 29, 2013, 876547.
9. [9] Polish diabetes association clinical recommendations for the management of patients with diabetes. Clin. Diabetol. 2:Suppl. A (2013), 3–52.
10. [10] Standards of medical care in diabetes-2015: summary of revisions. Diabetes Care, 38(Suppl), 2015, S4.
11. [11] Wright, R.J., Newby, D.E., Stirling, D., Ludlam, C.A., Macdonald, I.A., Frier, B.M., Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33:7 (2010), 1591–1597.